Publicaciones en colaboración con investigadores/as de Hospital Ruber Internacional (5)

2024

  1. Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

    eClinicalMedicine, Vol. 71

2022

  1. Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study

    International Journal of Infectious Diseases, Vol. 123, pp. 97-103

2020

  1. The persistent breach between evidence and practice in the prevention of surgical site infection. Qualitative study

    International Journal of Surgery

2019

  1. Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm

    Current Breast Cancer Reports, Vol. 11, Núm. 4, pp. 248-258

2018

  1. Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

    Annals of Oncology, Vol. 29, Núm. 4, pp. 881-887